<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Experiment title: Structural studies on cell-cycle proteins in complex with small molecule inhibitors Experiment number</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2000-08-23">23 August, 2000</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><surname>Ls-1526</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">E</forename><surname>Mitchell</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Martin</forename><surname>Noble</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Jane</forename><surname>Endicott</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Louise</forename><surname>Johnson</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="laboratory">Laboratory of Molecular</orgName>
								<orgName type="institution">ADDI group</orgName>
								<address>
									<addrLine>Biophysics Rex Richards Building South Parks Road Oxford</addrLine>
									<postCode>OX1 3QU</postCode>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Newcastle Universty</orgName>
								<address>
									<country key="GB">U.K</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Experiment title: Structural studies on cell-cycle proteins in complex with small molecule inhibitors Experiment number</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2000-08-23">23 August, 2000</date>
						</imprint>
					</monogr>
					<idno type="MD5">37E75EE91B34E988A2904AAEE5B0010E</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T15:05+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>ID14-EH3</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumour Cell Growth Inhibition Profiles</head><p>Substituted guanines and pyrimidines were tested as inhibitors of cyclin B1/CDK1 and cyclin A3/CDK2 and soaked into crystals of monomeric CDK2. O6-Cyclohexylmethylguanine (NU2058) was a competitive inhibitor of CDK1 and CDK2 with respect to ATP, (Ki values: CDK1, 5 ± 1 µM; CDK2, 12 ± 3 µM) and formed a triplet of hydrogen bonds (ie NH-9 to Glu 81, N-3 to Leu 83, and 2-NH2 to Leu 83). Hydrogen bonding interactions between NU2058 and CDK2 are shown in Figure <ref type="figure">1</ref>. The triplet of hydrogen bonding and CDK inhibition was reproduced by 2,6-diamino-4-cyclohexylmethoxy-5-nitrosopyrimidine (NU6027, Ki values: CDK1, 2.5 ± 0.4 µM; CDK2, 1.3 ± 0.2 µM). X-ray data collection and refinement statistics</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>pattern of selectivity disctinct from flavopiridol and olomoucine. These CDK inhibition and chemosensitivity data indicate that the distinct mode of binding of NU2058 and NU6027 has direct consequences for enzyme and cell growth inhibition.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 1 Interaction of NU2058 with monomeric CDK2</head></div><figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="2,42.00,117.00,250.00,256.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="2,42.00,437.00,333.00,324.00" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
